OrbusNeich Medical

TriMed Staff | | Cardiovascular Business | Patient Care
OrbusNeich Medical (Booth 1011) is highlighting data from clinical trials of its Genous bio-engineered R stent, which is not commercially available in the U.S., to prevent thrombosis and minimize restenosis.

Robbert de Winter, MD, PhD, of the Academic Medical Center in Amsterdam will provide a Genous clinical program update in an oral presentation at 4:10 pm on Monday, Oct. 13 in Ballroom C, including interim follow-up data from e-HEALING, a monitored, multi-center, global prospective registry with 5,000 enrolled patients.  

The Genous drug-eluting stent, which is coated with an antibody, captures a patient’s endothelial progenitor cells (EPCs) to accelerate the natural healing process. When attracted to the surface of Genous, EPCs rapidly form an endothelial layer over the stent that provides protection against thrombus and minimizes restenosis.

TriMed Staff

Related Content

Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.